Abstract
Over the last decade, nano-emulsion has gained a considerable interest in biomedical applications. The reason is simple, and lies in the combination of several advantages of this nano-carrier. Nano-emulsion consists of a dispersion of oil nano-droplets in a water phase, sizing from 20 to 200 nm. First advantage of nano-emulsions is their huge stability; Second is their very simple formulation; Third is their non-toxicity; And fourth is their very important loading capability of lipophilic or oil-soluble molecules in the oily core of the nano-droplets. On the other hand, if the formulation is easy, tailoring the nano-emulsions for a given application, optimizing the processes, functionalizing the droplets surface, and targeting organs or cancerous tumors remains a challenge. This chapter aims to draw an overview of the different aspects of nano-emulsions formulations and applications. A first part regards the different fabrication processes, followed by biomedical applications of nano-emulsions, in vivo fate, biodistribution, pharmacokinetics, targeting, applications as nanomedicines and drug delivery systems. Clinical applications of nano-emulsions are also discussed, as well as their applications as contrast agent for the main different imaging modalities, X-ray imaging, fluorescence imaging and magnetic resonance imaging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ALA:
-
Aminolaevulinic acid
- AK:
-
Actinic keratosis
- BF200 ALA:
-
BF200 aminolaevulinic acid
- CMC:
-
Critical micelle concentration
- CT:
-
Computed tomography
- DLS:
-
Dynamic light scattering
- DTPA- PE:
-
Diethylenetriaminepentaacetic acid phosphoethanolamine
- DTX:
-
Docetaxel
- EPR:
-
Enhanced permeation and retention
- HLB:
-
Hydrophilic-lipophilic balance
- IONPs:
-
Iron oxide nanoparticles
- LNP:
-
Lipid nanoparticle
- MAL:
-
5-aminolaevulinic acid
- MRI:
-
Magnetic resonance imaging
- NIR:
-
Near infrared
- NIRF:
-
Near infrared fluorescence
- NMR:
-
Nuclear magnetic resonance
- NPs:
-
Nanoparticle
- PAV:
-
Prednisolone acetate valerate
- PBS:
-
Phosphate buffer saline
- PET:
-
Positron emission tomography
- PDI:
-
Polydispersity index
- PEG:
-
Polyethylene glycol
- PFCs:
-
Perfluorocarbons
- PFPE:
-
Perfluoropolyether
- QDs:
-
Quantum-dots
- RES:
-
Rethiculoendothelial system
- SPECT:
-
Single photon emission computed tomography
- SPIO:
-
Superparamagnetic iron oxide
- TEM:
-
Transmission electron microscopy
- TXT:
-
Taxotere®
References
Ahrens ET, Flores R, Xu H, Morel PA (2005) In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 23(8):983–987
Almajdub M, Nejjari M, Poncet G, Magnier L, Chereul E, Roche C, Manier M (2007) In vivo high-resolution X-ray microtomographyfor liver and spleen tumor assessment in mice. Contrast Media Mol Imaging 2:88–93
Anayama T, Nakajima T, Dunne M, Zheng J, Allen C, Driscoll B, Vines D, Keshavjee S, Jaffray D, Yasufuku K (2013) A novel minimally invasive technique to create a rabbit VX2 lung tumor model for nano-sized image contrast and interventional studies. PLoS One 8, e67355
ANSM. Résumé des caractéristiques du produit – MEDIALIPIDE 20 POUR CENT, émulsion pour perfusion - Base de données publique des médicaments.
ANSM. Résumé des caractéristiques du produit – NEORAL 100 mg/ml, solution buvable - Base de données publique des médicaments.
ANSM. Résumé des caractéristiques du produit – PROPOFOL LIPURO 1 % (10 mg/ml), émulsion injectable ou pour perfusion – Base de données publique des médicaments.
Anton N, Vandamme TF (2009) The universality of low-energy nano-emulsification. Int J Pharm 377:142–147
Aprahamian M, Bour G, Akladios CY, Fylaktakidou K, Greferath R, Soler L, Marescaux J, Egly JM, Lehn JM, Nicolau C (2011) Myo-InositolTrisPyroPhosphate treatment leads to HIF-1α suppression and eradication of early hepatoma tumors in rats. ChemBioChem 12(5):777–783
Attia M, Anton N, Chiper MC, Akasov R, Anton H, Messaddeq N, Fournel S, Klymchenko A, Mély Y, Vandamme TF (2014) Biodistribution of X-ray iodinated contrast agent in nano-emulsions is controlled by the chemical nature of the oily core. ACS Nano 8(10):10537–10550
Attia MF, Anton N, Akasov R, Chiper M, Markvicheva E, Vandamme TF (2015) Biodistribution and toxicity of X-ray iodinated contrast agent in nano-emulsions in function of their size. Pharm Res 33(3):603–614
Béduneau A, Hindré F, Clavreul A, Leroux JC, Saulnier P, Benoit JP (2008) Brain targeting using novel lipid nanovectors. J Control Release 126(1):44–49
Boll H, Nittka S, Doyon F, Neumaier M, Marx A, Kramer M, Groden C, Brockmann MA (2011) Micro-CT based experimental liver imaging using a nanoparticulate contrast agent: a longitudinal study in mice. PLoS One 6:e25692–e25697
Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, Bawendi MG, Frangioni JV (2007) Renal clearance of nanoparticles. Nat Biotechnol 25:1165–1170
Delmas T, Piraux H, Couffin AC, Texier I, Vinet F, Poulin P, Cates ME, Bibette J (2011) How to prepare and stabilize very small nanoemulsions. Langmuir 27:1683–1692
Ding J, Wang Y, Ma M, Zhang Y, Lu S, Jiang Y, Qi C, Luo S, Dong G, Wen S, An Y, Gu N (2013) CT/fluorescence dual-modal nanoemulsion platform for investigating atherosclerotic plaques. Biomaterials 34:209–216
Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Helwig C, Foguet M, Schmitz B, Lübbert H, Szeimies R-M, Group A-CS (2012) Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol 166:137–146
Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Hahn S, Pabst G, Voss D, Foguet M, Schmitz B, Lübbert H, Szeimies R-M, Group A-CS, Group A-CS (2013) Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol 168:825–836
Dubey PK, Kumar A (2005) Pain on injection of lipid-free propofol and propofol emulsion containing medium-chain triglyceride: a comparative study. Anesth Analg 101(4):1060–1062
Fang J, Nakamura H, Maeda H (2001) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–151
Flögel U, Ding Z, Hardung H, Jander S, Reichmann G, Jacoby C, Schubert R, Schrader J (2008) In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 118(2):140–148
Gianella A, Jarzyna PA, Mani V, Ramachandran S, Calcagno C, Tang J, Kann B, Dijk WJR, Thijssen VL, Griffioen AW, Storm G, Fayad ZA, Mulder WJM (2011) Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. ACS Nano 5(6):4422–4433
Goutayer M, Dufort S, Josserand V, Royère A, Heinrich E, Vinet F, Bibette J, Coll JL, Texier I (2010) Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur J Pharm Biopharm 75:137–147
Hallouard F, Briançon S, Anton N, Li X, Vandamme TF, Fessi H (2013) Poly(ethylene glycol)-poly(ε-caprolactone) iodinated nanocapsules as contrast agents for X-ray imaging. Pharm Res 30:2023–2035
Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 95:4607–4612
Ijzerman M, Backer J, Flack M, Robinson P (2010a) Efficacy of topical nanoemulsion (NB-002) for the treatment of distal subungual onychomycosis: a randomized, double-blind, vehicle-controlled trial. J Am Acad Dermatol 62:AB76
Ijzerman M, Backer J, Flack M, Robinson P (2010b) Forty-two–week safety study of topical nanoemulsion (NB-002) for the treatment of mild to moderate distal subungual onychomycosis: a randomized, double-blind, vehicle-controlled trial. J Am Acad Dermatol 62:AB77
Jain RK (1999) Transport of molecules, particles, and cells in solid tumors. Annu Rev Biomed Eng 1:241–263
Jakhmola A, Anton N, Anton H, Messaddeq N, Hallouard F, Klymchenko A, Mely Y, Vandamme TF (2014) Poly-ε-caprolactone tungsten oxide nanoparticles as a contrast agent for X-ray computed tomography. Biomaterials 35(9):2981–2986
Jarzyna PA, Skajaa T, Gianella A, Cormode DP, Samber DD, Dickson SD, Chen W, Griffioen AW, Fayad ZA, Mulder WJM (2009) Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging. Biomaterials 30:6947–6954
Karathanasis E, Suryanarayanan S, Balusu SR, McNeeley K, Sechopoulos I, Karellas A, Annapragada AV, Bellamkonda RV (2009) Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology 250(2009):398–406
Khalid MN, Simard P, Hoarau D, Dragomir A, Leroux JC (2006) Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm Res 23(4):752–758
Kircik L, Jones TM, Jarratt M, Flack MR, Ijzerman M, Ciotti S, Sutcliffe J, Boivin G, Stanberry LR, Baker JR, N.-S. Group (2012) Treatment with a novel topical nanoemulsion (NB-001) speeds time to healing of recurrent cold sores. J Drugs Dermatol 11:970–977
Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268(1):235–237
Klymchenko AS, Roger E, Anton N, Anton H, Shulov I, Vermot J, Mély Y, Vandamme TF (2012) Highly lipophilic fluorescent dyes in nano-emulsions: towards bright non-leaking nano-droplets. RSC Adv 2:11876–11886
Kulkarni SA, Feng SS (2013) Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res 30:2512–2522
Lanza GM, Winter PM, Neubauer AM, Caruthers SD, Hockett FD, Wickline SA (2005) 1H/19 F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. Curr Top Dev Biol 70:57–76
Li X, Anton N, Zubera G, Zhao M, Messaddeq N, Hallouard F, Fessie H, Vandamme TF (2013) Iodinated α-tocopherol nano-emulsions as non-toxic contrast agents for preclinical X-ray imaging. Biomaterials 34:481–491
Li X, Anton N, Zuber G, Vandamme TF (2014) Contrast agents for preclinical targeted X-ray imaging. Adv Drug Deliv Rev 76:116–133
Martiniova L, Schimel D, Lai EW, Limpuanfthip A, Kvetnansky R, Pacak K (2010) In vivo micro CT imaging for liver lesions in small animal models. Methods 50:20–25
Neittaanmäki-Perttu N, Karppinen T t, Grönroos M, Tani T t, Snellman E (2014) Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate. Br J Dermatol 171:1172–1180
Nöth U, Morrissey SP, Deichmann R, Jung S, Adolf H, Haase A, Lutz J (1997) Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis. Artif Cells Blood Substit Immobil Biotechnol 25(3):243–254
O’Hanlon CE, Amede KG, O’Hear MR, Janjic JM (2012) NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging. J Fluor Chem 137:27–33
Owens DE, Peppas NA (2006) Opsonization, biodistribution and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102
Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, Nolta JA, Caruthers SD, Lanza GM, Wickline SA (2007) 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J 21(8):1647–1654
Rodrigues TA, Alexandrino RA, Kanczuk ME, Gozzani JL, Mathias LA, Da ST (2012) A comparative study of non-lipid nanoemulsion of propofol with solutol and propofol emulsion with lecithin. Rev Bras Anestesiol 62(3):325–334
Stanberry LR, Simon JK, Johnson C, Robinson PL, Morry J, Flack MR, Gracon S, Myc A, Hamouda T, Baker JR Jr (2012) Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens. Vaccine 30:307–316
Szeimies R-M, Radny P, Sebastian M, Borrosch F, Dirschka T, Krähn-Senftleben G, Reich K, Pabst G, Voss D, Foguet M, Gahlmann R, Lübbert H, Reinhold U (2010) Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study. Br J Dermatol 163:386–394
Taisne L, walstra B, Cabane B (1996) Transfer of oil between emulsion droplets. J Colloid Interface Sci 184:378–390
Tiwari S, Tan YM, Amiji M (2006) Preparation and in vitro characterization of multifunctional nanoemulsions for simultaneous MR imaging and targeted drug delivery. J Biomed Nanotechnol 2:1–8
Torchilin V-P, Trubetskoy V-S (1995) Wich polymers can make nanoparticulates drug carriers long circulating? Adv Drug Deliv Rev 16(2–3):141–155
Treanor JJ, Essink B, Hull S, Reed S, Izikson R, Patriarca P, Goldenthal KL, Kohberger R, Dunkle LM (2013) Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE + GLA) adjuvant. Vaccine 31:5760–5765
Zheng J, Jaffray D, Allen C (2009) Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model. Mol Pharm 6(2):571–580
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Anton, N., Hallouard, F., Attia, M.F., Vandamme, T.F. (2016). Nano-emulsions for Drug Delivery and Biomedical Imaging. In: Prokop, A., Weissig, V. (eds) Intracellular Delivery III. Fundamental Biomedical Technologies. Springer, Cham. https://doi.org/10.1007/978-3-319-43525-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-43525-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43523-7
Online ISBN: 978-3-319-43525-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)